← Back to Search

FAZA PET/MRI scan for Kidney Fibrosis

N/A

Waitlist Available

Led By Patrick Veit-Haibach, MD

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion once patient with stable graft function and minimal or no fibrosis on time zero biopsy and age matched graft age is identified. up to 60 months

Awards & highlights

Study Summary

This trial aims to develop non-invasive tools to detect the early stages of fibrosis in kidney transplants, reducing risks and improving patient care.

Eligible Conditions

Kidney Graft Fibrosis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion once patient with stable graft function and minimal or no fibrosis on time zero biopsy and age matched graft age is identified. up to 60 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion once patient with stable graft function and minimal or no fibrosis on time zero biopsy and age matched graft age is identified. up to 60 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion once patient with stable graft function and minimal or no fibrosis on time zero biopsy and age matched graft age is identified. up to 60 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

To image patients with different states of allograft function impairment and ideally find an imaging-based way to monitor those patients after transplantation

Secondary outcome measures

Performing urine assays whereby AngII activity proteins in urine to predict the survival/viability outcome of the kidney allograft

Trial Design

1Treatment groups

Experimental Treatment

Group I: FAZA PET/MRI scanExperimental Treatment1 Intervention

FAZA PET/MRI scan before the standard of care biopsy for case group

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

FAZA PET/MRI scan

2018

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor

1,476 Previous Clinical Trials

485,149 Total Patients Enrolled

Patrick Veit-Haibach, MDPrincipal InvestigatorUniversity Health Network, Toronto

7 Previous Clinical Trials

375 Total Patients Enrolled

Media Library

FAZA PET/MRI scan Clinical Trial Eligibility Overview. Trial Name: NCT05638308 — N/A

Kidney Fibrosis Research Study Groups: FAZA PET/MRI scan

Kidney Fibrosis Clinical Trial 2023: FAZA PET/MRI scan Highlights & Side Effects. Trial Name: NCT05638308 — N/A

FAZA PET/MRI scan 2023 Treatment Timeline for Medical Study. Trial Name: NCT05638308 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an ongoing opportunity to enroll in this research project?

"Clinical trials.gov hosts information confirming that this clinical trial is still open for recruitment and was last modified on November 25th 2022, having first been posted in May 2018."

Answered by AI

What is the participant count of this clinical trial?

"Yes, the clinicaltrials.gov website indicates that this medical trial is still recruiting for participants. It was initially posted on May 26th 2018 and most recently updated November 25th 2022, with 40 patients sought from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

FAZA PETMRI Kidney Graft Fibrosis Study

2018. "FAZA PETMRI Kidney Graft Fibrosis Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05638308.